109 related articles for article (PubMed ID: 1560105)
1. A murine model of herpes simplex virus-induced ocular disease for antiviral drug testing.
Brandt CR; Coakley LM; Grau DR
J Virol Methods; 1992 Mar; 36(3):209-22. PubMed ID: 1560105
[TBL] [Abstract][Full Text] [Related]
2. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
3. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection.
Epstein SP; Nurozler M; Smetana CR; Asbell PA
Cornea; 2001 Jul; 20(5):495-500. PubMed ID: 11413405
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
[TBL] [Abstract][Full Text] [Related]
7. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447
[TBL] [Abstract][Full Text] [Related]
8. Cidofovir and experimental herpetic stromal disease.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.
Valluri S; Fleming TP; Laycock KA; Tarle IS; Goldberg MA; Garcia-Ferrer FJ; Essary LR; Pepose JS
Cornea; 1997 Sep; 16(5):556-9. PubMed ID: 9294689
[TBL] [Abstract][Full Text] [Related]
10. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
11. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
12. Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application.
Berdugo M; Larsen IV; Abadie C; Deloche C; Kowalczuk L; Touchard E; Dubielzig R; Brandt CR; Behar-Cohen F; Combette JM
Antimicrob Agents Chemother; 2012 Mar; 56(3):1390-402. PubMed ID: 22203590
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glycoprotein inhibitors alone and in combination with trifluridine in the treatment of murine herpetic keratitis.
Gordon YJ; Cheng KP; Araullo-Cruz T; Romanowski E; Johnson BJ; Blough HA
Curr Eye Res; 1986 Feb; 5(2):93-9. PubMed ID: 3082600
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic action of meliacine, a plant-derived antiviral, on HSV-induced ocular disease in mice.
Pifarré MP; Berra A; Coto CE; Alché LE
Exp Eye Res; 2002 Sep; 75(3):327-34. PubMed ID: 12384095
[TBL] [Abstract][Full Text] [Related]
16. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
Carter SB; Cohen EJ
Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
[TBL] [Abstract][Full Text] [Related]
17. Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model.
Bhattacharjee PS; Neumann DM; Foster TP; Clement C; Singh G; Thompson HW; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4263-8. PubMed ID: 18515564
[TBL] [Abstract][Full Text] [Related]
18. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
[TBL] [Abstract][Full Text] [Related]
19. Geldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model.
Wu X; Tao P; Nie H
Clin Exp Ophthalmol; 2011 Nov; 39(8):779-83. PubMed ID: 22050565
[TBL] [Abstract][Full Text] [Related]
20. A novel rare sugar inhibitor of murine herpes simplex keratitis.
Muniruzzaman S; McIntosh M; Hossain A; Izumori K; Bhattacharjee PS
J Pharmacol Sci; 2016 Jun; 131(2):126-30. PubMed ID: 27262904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
